SCHEMBL2331197

SCHEMBL2331197

COc1ccc2ccc([Sn](C)(C)C)cc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 2/20 0.57
▸ CYP1A2 P05177 2/20 0.57
▸ RAB9A P51151 2/20 0.49
▸ HSD17B1 P14061 1/20 0.46
▸ HSD17B2 P37059 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.43
▸ GSTP1 P09211 1/20 0.43
▸ CYP11B2 P19099 2/20 0.42
▸ HTR1A P08908 1/20 0.42
▸ HTR1D P28221 1/20 0.42
▸ HTR1B P28222 1/20 0.42
▸ CYP17A1 P05093 1/20 0.42
▸ NCF1 P14598 1/20 0.42
▸ MEN1 O00255 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ AKR1C3 P42330 3/20 0.40
▸ AKR1C2 P52895 3/20 0.40
▸ PTGS1 P23219 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5952852 0.96 CYP2A6 (0.56) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL443528 0.82 CYP2A6 (0.80) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL29367032 0.82 CYP2A6 (0.80) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL8499457 0.82 PDE4A (0.41) CYP2A6CYP1A2RAB9AKDM4ECYP17A1
SCHEMBL1793381 0.80 CYP2A6 (0.38) CYP2A6CYP1A2
SCHEMBL6891918 0.78 CYP1A2 (0.71) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL2249185 0.78 CYP1A2 (0.71) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL7452675 0.78 CYP1A2 (0.71) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL7451812 0.78 CYP1A2 (0.71) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2
SCHEMBL7456084 0.78 CYP1A2 (0.71) CYP2A6CYP1A2RAB9AHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0853618-B1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL -AZAHETEROCYCLYLAMIDE COMPOUNDS AVENTIS PHARMA INC (US) 2011-08-17 — — EP disclosed
EP-0853618-A4 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHONE POULENC RORER PHARMA (US) 2000-03-15 — — EP disclosed
US-5958918-A Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N- (aminominomethyl)phenylalkyl!-azaheterocyclylamide compounds RHONE-POULENC RORER PHARMACEUTICALS INC. 1999-09-28 — — US disclosed
EP-0853618-A1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1998-07-22 — — EP disclosed
WO-1996040679-A1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N-[(AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-12-19 — — WO disclosed
Send feedback